Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis

por Parravicini, Chiara, Lecca, Davide, Marangon, Davide, Coppolino, Giusy Tindara, Daniele, Simona, Bonfanti, Elisabetta, Fumagalli, Marta, Raveglia, Luca, Martini, Claudia, Gianazza, Elisabetta, Trincavelli, Maria Letizia, Abbracchio, Maria P., Eberini, Ivano
Publicado 2020